240 related articles for article (PubMed ID: 31799623)
1. Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease.
Cantero JL; Atienza M; Lage C; Zaborszky L; Vilaplana E; Lopez-Garcia S; Pozueta A; Rodriguez-Rodriguez E; Blesa R; Alcolea D; Lleo A; Sanchez-Juan P; Fortea J;
Cereb Cortex; 2020 Apr; 30(4):2083-2098. PubMed ID: 31799623
[TBL] [Abstract][Full Text] [Related]
2. Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment.
Cantero JL; Zaborszky L; Atienza M
Cereb Cortex; 2017 Aug; 27(8):3881-3889. PubMed ID: 27371762
[TBL] [Abstract][Full Text] [Related]
3. Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
Fernández-Cabello S; Kronbichler M; Van Dijk KRA; Goodman JA; Spreng RN; Schmitz TW;
Brain; 2020 Mar; 143(3):993-1009. PubMed ID: 32203580
[TBL] [Abstract][Full Text] [Related]
4. Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.
Yoo HS; Kim HK; Lee JH; Chun JH; Lee HS; Grothe MJ; Teipel S; Cavedo E; Vergallo A; Hampel H; Ryu YH; Cho H; Lyoo CH
J Alzheimers Dis; 2024; 99(1):145-159. PubMed ID: 38640150
[TBL] [Abstract][Full Text] [Related]
5. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease.
Cavedo E; Grothe MJ; Colliot O; Lista S; Chupin M; Dormont D; Houot M; Lehéricy S; Teipel S; Dubois B; Hampel H;
Sci Rep; 2017 Sep; 7(1):11706. PubMed ID: 28916821
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
7. The basal forebrain volume reduction detected by MRI does not necessarily link with the cholinergic neuronal loss in the Alzheimer's disease mouse model.
Zhou XA; Ngiam G; Qian L; Sankorrakul K; Coulson EJ; Chuang KH
Neurobiol Aging; 2022 Sep; 117():24-32. PubMed ID: 35640461
[TBL] [Abstract][Full Text] [Related]
8. Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome.
Rozalem Aranha M; Iulita MF; Montal V; Pegueroles J; Bejanin A; Vaqué-Alcázar L; Grothe MJ; Carmona-Iragui M; Videla L; Benejam B; Arranz J; Padilla C; Valldeneu S; Barroeta I; Altuna M; Fernández S; Ribas L; Valle-Tamayo N; Alcolea D; González-Ortiz S; Bargalló N; Zetterberg H; Blennow K; Blesa R; Wisniewski T; Busciglio J; Cuello AC; Lleó A; Fortea J
Alzheimers Dement; 2023 Nov; 19(11):4817-4827. PubMed ID: 37021589
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease.
Schmitz TW; Soreq H; Poirier J; Spreng RN
J Neurosci; 2020 Feb; 40(9):1931-1942. PubMed ID: 31915256
[TBL] [Abstract][Full Text] [Related]
10. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects.
Grothe MJ; Ewers M; Krause B; Heinsen H; Teipel SJ;
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S344-53. PubMed ID: 24418052
[TBL] [Abstract][Full Text] [Related]
11. Increased functional connectivity between nucleus basalis of Meynert and amygdala in cognitively intact elderly along the Alzheimer's continuum.
Zeng Q; Qiu T; Li K; Luo X; Wang S; Xu X; Liu X; Hong L; Li J; Huang P; Zhang M;
Neuroimage Clin; 2022; 36():103256. PubMed ID: 36451361
[TBL] [Abstract][Full Text] [Related]
12. FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry.
Aghourian M; Aumont É; Grothe MJ; Soucy JP; Rosa-Neto P; Bedard MA
J Neuroimaging; 2021 Nov; 31(6):1077-1081. PubMed ID: 34462992
[TBL] [Abstract][Full Text] [Related]
13. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease.
Xia Y; Maruff P; Doré V; Bourgeat P; Laws SM; Fowler C; Rainey-Smith SR; Martins RN; Villemagne VL; Rowe CC; Masters CL; Coulson EJ; Fripp J
Neurobiol Aging; 2023 Dec; 132():120-130. PubMed ID: 37801885
[TBL] [Abstract][Full Text] [Related]
15. Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
Lin CP; Frigerio I; Boon BDC; Zhou Z; Rozemuller AJM; Bouwman FH; Schoonheim MM; van de Berg WDJ; Jonkman LE
Brain; 2022 Aug; 145(8):2869-2881. PubMed ID: 35259207
[TBL] [Abstract][Full Text] [Related]
16. Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.
Grothe M; Heinsen H; Teipel SJ
Biol Psychiatry; 2012 May; 71(9):805-13. PubMed ID: 21816388
[TBL] [Abstract][Full Text] [Related]
17. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD).
Scheef L; Grothe MJ; Koppara A; Daamen M; Boecker H; Biersack H; Schild HH; Wagner M; Teipel S; Jessen F
Neuroimage Clin; 2019; 21():101612. PubMed ID: 30555006
[TBL] [Abstract][Full Text] [Related]
18. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia.
Grothe MJ; Schuster C; Bauer F; Heinsen H; Prudlo J; Teipel SJ
J Neurol; 2014 Oct; 261(10):1939-48. PubMed ID: 25059393
[TBL] [Abstract][Full Text] [Related]
19. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
20. Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
Daamen M; Scheef L; Li S; Grothe MJ; Gaertner FC; Buchert R; Buerger K; Dobisch L; Drzezga A; Essler M; Ewers M; Fliessbach K; Herrera Melendez AL; Hetzer S; Janowitz D; Kilimann I; Krause BJ; Lange C; Laske C; Munk MH; Peters O; Priller J; Ramirez A; Reimold M; Rominger A; Rostamzadeh A; Roeske S; Roy N; Scheffler K; Schneider A; Spottke A; Spruth EJ; Teipel SJ; Wagner M; Düzel E; Jessen F; Boecker H;
J Alzheimers Dis; 2023; 95(3):1013-1028. PubMed ID: 37638433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
